A study of some hepatic immunological markers, iron load and virus genotype in chronic hepatitis C

Journal of Hepatology

Volumn 41, Issue 2, 2004, Pages 319-326

  Cardoso, Elsa Maria ^a,b   Duarte, Miguel Angelo ^c   Ribeiro, Eduarda ^a,c   Rodrigues, Pedro ^a,c   Hultcrantz, Rolf ^d   Sampaio, Paula ^a   Ehrlich, Rachel ^e   Carvalho, João ^f   Fraga, José ^f   De Sousa, Maria ^a,c  

^a UNIVERSITY OF PORTO   (Portugal)

^b UNIVERSITY INSTITUTE OF HEALTH SCIENCES IUCS   (Portugal)

^c UNIVERSITY OF PORTO   (Portugal)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^e TEL AVIV UNIVERSITY   (Israel)

^f Vila Nova de Gaia/Espinho Hospital Center   (Portugal)

Author keywords

Hepatitis C virus; HFE; IFN; Liver; MHC I

Indexed keywords

ALPHA2A INTERFERON; ALPHA2B INTERFERON; BETA 2 MICROGLOBULIN; BIOCHEMICAL MARKER; CD68 ANTIGEN; CD8 ANTIGEN; HFE PROTEIN; IRON; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PEGINTERFERON ALPHA2A; PEGINTERFERON ALPHA2B; RIBAVIRIN;

ADULT; ARTICLE; CELL COUNT; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOTOXICITY; DENDRITIC CELL; DRUG RESPONSE; ENDOTHELIUM CELL; FEMALE; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; KUPFFER CELL; LIVER BIOPSY; LIVER SINUSOID; MALE; PORTAL VEIN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION;

ADULT; ANTIVIRAL AGENTS; BIOLOGICAL MARKERS; ENDOTHELIAL CELLS; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; INTERFERONS; IRON; KUPFFER CELLS; LIVER; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MUTATION; SINGLE-BLIND METHOD; TREATMENT OUTCOME; VIRAL LOAD;

EID: 4444314259     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2004.04.027     Document Type: Article

References (39)

1. Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium. J Viral Hepat. 6:1999;35-47
2. Bonkovsky H.L. Iron as a comorbid factor in chronic viral hepatitis. Am J Gastroenterol. 97:2002;1-4
3. Bonkovsky H.L., Banner B.F., Rothman A.L. Iron and chronic viral hepatitis. Hepatology. 25:1997;759-768
4. Fargion S., Fracanzani A.L., Sampietro M., Molteni V., Boldorini R., Mattioli M., et al. Liver iron influences the response to interferon alpha therapy in chronic hepatitis C. Eur J Gastroenterol Hepatol. 9:1997;497-503
5. Ikura Y., Morimoto H., Johmura H., Fukui M., Sakurai M. Relationship between hepatic iron deposits and response to interferon in chronic hepatitis C. Am J Gastroenterol. 91:1996;1367-1373
6. Olynyk J.K., Reddy K.R., Di Bisceglie A.M., Jeffers L.J., Parker T.I., Radick J.L., et al. Hepatic iron concentration as a predictor of response to interferon alfa therapy in chronic hepatitis C. Gastroenterology. 108:1995;1104-1109
7. Van Thiel D.H., Friedlander L., Fagiuoli S., Wright H.I., Irish W., Gavaler J.S. Response to interferon alpha therapy is influenced by the iron content of the liver. J Hepatol. 20:1994;410-415
8. Chang K.M., Thimme R., Melpolder J.J., Oldach D., Pemberton J., Moorhead-Loudis J., et al. Differential CD4(+) and CD8(+) T-cell responsiveness in hepatitis C virus infection. Hepatology. 33:2001;267-276
9. Freeman A.J., Pan Y., Harvey C.E., Post J.J., Law M.G., White P.A., et al. The presence of an intrahepatic cytotoxic T lymphocyte response is associated with low viral load in patients with chronic hepatitis C virus infection. J Hepatol. 38:2003;349-356
10. Liu C., Zhu H., Tu Z., Xu Y.L., Nelson D.R. CD8+T-cell interaction with HCV replicon cells: evidence for both cytokine- and cell-mediated antiviral activity. Hepatology. 37:2003;1335-1342
11. Shoukry N.H., Grakoui A., Houghton M., Chien D.Y., Ghrayeb J., Reimann K.A., et al. Memory CD8+ T cells are required for protection from persistent hepatitis C virus infection. J Exp Med. 197:2003;1645-1655
12. Sreenarasimhaiah J., Jaramillo A., Crippin J., Lisker-Melman M., Chapman W.C., Mohanakumar T. Lack of optimal T-cell reactivity against the hepatitis C virus is associated with the development of fibrosis/cirrhosis during chronic hepatitis. Hum Immunol. 64:2003;224-230
13. Cardoso E.M., Hagen K., de Sousa M., Hultcrantz R. Hepatic damage in C282Y homozygotes relates to low numbers of CD8+cells in the liver lobuli. Eur J Clin Invest. 31:2001;45-53
14. Erhardt A., Maschner-Olberg A., Mellenthin C., Kappert G., Adams O., Donner A., et al. HFE mutations and chronic hepatitis C: H63D and C282Y heterozygosity are independent risk factors for liver fibrosis and cirrhosis. J Hepatol. 38:2003;335-342
15. Bonkovsky H.L., Troy N., McNeal K., Banner B.F., Sharma A., Obando J., et al. Iron and HFE or TfR1 mutations as comorbid factors for development and progression of chronic hepatitis C. J Hepatol. 37:2002;848-854
16. Blanc J.F., De Ledinghen V., Bernard P.H., de Verneuil H., Winnock M., Le Bail B., et al. Increased incidence of HFE C282Y mutations in patients with iron overload and hepatocellular carcinoma developed in non-cirrhotic liver. J Hepatol. 32:2000;805-811
17. Negro F., Samii K., Rubbia-Brandt L., Quadri R., Male P.J., Zarski J.P., et al. Hemochromatosis gene mutations in chronic hepatitis C patients with and without liver siderosis. J Med Virol. 60:2000;21-27
18. Hezode C., Cazeneuve C., Coue O., Pawlotsky J.M., Zafrani E.S., Amselem S., et al. Hemochromatosis Cys282Tyr mutation and liver iron overload in patients with chronic active hepatitis C. Hepatology. 27:1998;306
19. Knoll A., Kreuzpaintner B., Kreuzpaintner E., Jilg W., Lock G., Hartmann A. Hemochromatosis mutation in hepatitis C: histopathology. Gastroenterology. 115:1998;1307-1309
20. Olynyk J.K., O'Neill R., Britton R.S., Bacon B.R. Determination of hepatic iron concentration in fresh and paraffin-embedded tissue: diagnostic implications. Gastroenterology. 106:1994;674-677
21. Oberkanins C., Kazemi-Shirazi L., Kury F., Polli C., Maier-Doberfberger T., Yeganehfar C., et al. Genotyping of common hereditary hemochromatosis mutations in microtiter plates. Eur J Hum Genet. 6:1998;62
22. Cardoso C.S., Oliveira P., Porto G., Oberkanins C., Mascarenhas M., Rodrigues P., et al. Comparative study of the two more frequent HFE mutations (C282Y and H63D): significant different allelic frequencies between the North and South of Portugal. Eur J Hum Genet. 9:2001;843-848
23. Ben-Arieh S.V., Zimerman B., Smorodinsky N.I., Yaacubovicz M., Schechter C., Bacik I., et al. Human cytomegalovirus protein US2 interferes with the expression of human HFE, a non-classical class I major histocompatibility complex molecule that regulates iron homeostasis. J Virol. 75:2001;10557-10562
24. Shindler K.S., Roth K.A. Double immunofluorescent staining using two unconjugated primary antisera raised in the same species. J Histochem Cytochem. 44:1996;1331-1335
25. Burgio V.L., Ballardini G., Artini M., Caratozzolo M., Bianchi F.B., Levrero M. Expression of co-stimulatory molecules by Kupffer cells in chronic hepatitis of hepatitis C virus etiology. Hepatology. 27:1998;1600-1606
26. Liang T.J., Rehermann B., Seeff L.B., Hoofnagle J.H. Pathogenesis, natural history, treatment, and prevention of hepatitis C. Ann Intern Med. 132:2000;296-305
27. Barbaro G., Di Lorenzo G., Ribersani M., Soldini M., Giancaspro G., Bellomo G., et al. Serum ferritin and hepatic glutathione concentrations in chronic hepatitis C patients related to the hepatitis C virus genotype. J Hepatol. 30:1999;774-782
28. Bastin J.M., Jones M., O'Callaghan C.A., Schimanski L., Mason D.Y., Townsend A.R. Kupffer cell staining by an HFE-specific monoclonal antibody: implications for hereditary haemochromatosis. Br J Haematol. 103:1998;931-941
29. Bridle K.R., Crawford D.H., Fletcher L.M., Smith J.L., Powell L.W., Ramm G.A. Evidence for a sub-morphological inflammatory process in the liver in haemochromatosis. J Hepatol. 38:2003;426-433
30. Cardoso C.S., de Sousa M. HFE, the MHC and hemochromatosis: paradigm for an extended function for MHC class I. Tissue Antigens. 61:2003;263-275
31. Zhang A.S., Xiong S., Tsukamoto H., Enns C.A. Localization of iron metabolism-related mRNAs in rat liver indicate that HFE is predominantly expressed in hepatocytes. Blood. 103:2004;1509-1514
32. Holmstrom P., Dzikaite V., Hultcrantz R., Melefors O., Eckes K., Stal P., et al. Structure and liver cell expression pattern of the HFE gene in the rat. J Hepatol. 39:2003;308-314
33. Cardoso C.S., Alves H., Mascarenhas M., Goncalves R., Oliveira P., Rodrigues P., et al. Co-selection of the H63D mutation and the HLA-A29 allele: a new paradigm of linkage disequilibrium? Immunogenetics. 53:2002;1002-1008
34. Tortorella D., Gewurz B.E., Furman M.H., Schust D.J., Ploegh H.L. Viral subversion of the immune system. Annu Rev Immunol. 18:2000;861-926
35. Konan K.V., Giddings T.H. Jr, Ikeda M., Li K., Lemon S.M., Kirkegaard K. Non-structural protein precursor NS4A/B from hepatitis C virus alters function and ultrastructure of host secretory apparatus. J Virol. 77:2003;7843-7855
36. Tardif K.D., Siddiqui A. Cell surface expression of major histocompatibility complex class I molecules is reduced in hepatitis C virus subgenomic replicon-expressing cells. J Virol. 77:2003;11644-11650
37. Herzer K., Falk C.S., Encke J., Eichhorst S.T., Ulsenheimer A., Seliger B., et al. Upregulation of major histocompatibility complex class I on liver cells by hepatitis C virus core protein via p53 and TAP1 impairs natural killer cell cytotoxicity. J Virol. 77:2003;8299-8309
38. Shaw M.L., McLauchlan J., Mills P.R., Patel A.H., McCruden E.A. Characterisation of the differences between hepatitis C virus genotype 3 and 1 glycoproteins. J Med Virol. 70:2003;361-372
39. Cardoso E.M., Macedo M.G., Rohrlich P., Ribeiro E., Silva M.T., Lemonnier F.A., et al. Increased hepatic iron in mice lacking classical MHC class I molecules. Blood. 100:2002;4239-4241